Global Nuclear Medicine/Radiopharmaceutic Market By Product Type (Diagnostic Radioisotopes, Therapeutic Radioisotopes) And By End-Users/Application (Oncology, Cardiology) Global Market Share, Forecast Data, In-Depth Analysis, And Detailed Overview, and Forecast, 2013 - 2026

Abstract Global Nuclear Medicine/Radiopharmaceutic Market is accounted for xx USD million in 2019 and is expected to reach xx USD million by 2026 growing at a CAGR of xx% during the forecast period. The report offers in-depth insights, revenue details, and other vital information regarding the global Nuclear Medicine/Radiopharmaceutic market and the various trends, drivers, restraints, opportunities, and threats in the target market till 2026. Nuclear Medicine/Radiopharmaceutic Market report covers size, share and forecast (value and volume) by regions, top players, product types and applications, with historical data along with forecast from 2019 to 2026; The report covers an in depth description, competitive scenario, wide product portfolio of key vendors and business strategy adopted by competitors along with their SWOT analysis, revenue, sales and Porter's Five Forces Analysis. By geography, this market has been segregated into five regions with revenue and growth rate of Nuclear Medicine/Radiopharmaceutic from 2013 to 2026, • North America (U.S., Canada, Mexico) • Europe (U.K., France, Germany, Spain, Italy, Central & Eastern Europe, CIS) • Asia Pacific (China, Japan, South Korea, ASEAN, India, Rest of Asia Pacific) • Latin America (Brazil, Rest of L.A.) • Middle East And Africa(Turkey, GCC, Rest of Middle East) The major players operating into Nuclear Medicine/Radiopharmaceutic Market include: Company Bracco Imaging Bayer Mallinckrodt Nordion Triad Isotopes Lantheus IBA Group GE Healthcare China Isotope & Radiation Jubilant Pharma Eli Lilly Advanced Accelerator Applications SIEMENS Dongcheng Navidea This report segments the Global Nuclear Medicine/Radiopharmaceutic Market as follows: Global Nuclear Medicine/Radiopharmaceutic Market: Type Segment Analysis Diagnostic Radioisotopes Therapeutic Radioisotopes Global Nuclear Medicine/Radiopharmaceutic Market: Application Segment Analysis Oncology Cardiology Others There are 13 chapters to put on view for Nuclear Medicine/Radiopharmaceutic Market: Chapter 1: Market Overview, Drivers, Restraints and Opportunities, Segmentation overview Chapter 2: Market competition by Manufacturers Chapter 3: Production by Regions Chapter 4: Consumption by Regions Chapter 5: Production, By Types, Revenue and Market share by Types Chapter 6: Consumption, By Applications, Market share (%) and Growth Rate by Applications Chapter 7: Complete profiling and analysis of Manufacturers Chapter 8: Manufacturing cost analysis, Raw materials analysis, Region-wise manufacturing expenses Chapter 9: Industrial Chain, Sourcing Strategy and Downstream Buyers Chapter 10: Marketing Strategy Analysis, Distributors/Traders Chapter 11: Market Effect Factors Analysis Chapter 12: Market Forecast Chapter 13: Nuclear Medicine/Radiopharmaceutic Research Findings and Conclusion, Appendix, methodology and data source Data type include capacity, production, market share, price, revenue, cost, gross, gross margin, growth rate, consumption, import, export have been determined using secondary sources and verified primary sources. Industry chain, manufacturing process, cost structure, marketing channel are also analyzed in this report. Industry Chain Analysis Raw Material and Suppliers Equipment and Suppliers Manufacturing Process Manufacturing Cost Structure Manufacturing Plants Distribution Analysis Available Customizations We can also provide customized report as per company's specific needs. We can also provide the customized separate regional or country-level reports, for the specific region as per client requirement.
Chapter 1 Industry Overview 1.1 Nuclear Medicine/Radiopharmaceutic Market Overview 1.1.1 Nuclear Medicine/Radiopharmaceutic Product Scope 1.1.2 Market Status and Outlook 1.2 Global Nuclear Medicine/Radiopharmaceutic Market Size and Analysis by Regions (2014-2019) 1.2.1 North America Nuclear Medicine/Radiopharmaceutic Market Status and Outlook 1.2.2 EU Nuclear Medicine/Radiopharmaceutic Market Status and Outlook 1.2.3 Japan Nuclear Medicine/Radiopharmaceutic Market Status and Outlook 1.2.4 China Nuclear Medicine/Radiopharmaceutic Market Status and Outlook 1.2.5 India Nuclear Medicine/Radiopharmaceutic Market Status and Outlook 1.2.6 Southeast Asia Nuclear Medicine/Radiopharmaceutic Market Status and Outlook 1.3 Global Nuclear Medicine/Radiopharmaceutic Market Segment by Types (2014-2025) 1.3.1 Global Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate Comparison by Types (2014-2025) 1.3.2 Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Types in 2018 1.3.3 Diagnostic Radioisotopes 1.3.4 Therapeutic Radioisotopes 1.3.5 Type 3 Others 1.4 Nuclear Medicine/Radiopharmaceutic Market by End Users/Application 1.4.1 Global Nuclear Medicine/Radiopharmaceutic Revenue (USD Mn) Comparison by Applications (2014-2025) 1.4.1 Oncology 1.4.2 Cardiology 1.4.3 Others Others Chapter 2 Global Nuclear Medicine/Radiopharmaceutic Competition Analysis by Players 2.1 Global Nuclear Medicine/Radiopharmaceutic Market Size (Million USD) by Players (2014-2019) 2.2 Competitive Status and Trend 2.2.1 Market Concentration Rate 2.2.2 Product/Service Differences 2.2.3 New Entrants 2.2.4 The Technology Trends in Future Chapter 3 Company (Top Players) Profiles and Key Data 3.1 Company 3.1.1 Company Profile 3.1.2 Main Business/Business Overview 3.1.3 Products, Services and Solutions 3.1.4 Company, Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) (2014-2019) 3.1.5 Recent Developments 3.2 Bracco Imaging 3.2.1 Company Profile 3.2.2 Main Business/Business Overview 3.2.3 Products, Services and Solutions 3.2.4 Bracco Imaging, Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) (2014-2019) 3.2.5 Recent Developments 3.3 Bayer 3.3.1 Company Profile 3.3.2 Main Business/Business Overview 3.3.3 Products, Services and Solutions 3.3.4 Bayer, Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) (2014-2019) 3.3.5 Recent Developments 3.4 Mallinckrodt 3.4.1 Company Profile 3.4.2 Main Business/Business Overview 3.4.3 Products, Services and Solutions 3.4.4 Mallinckrodt, Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) (2014-2019) 3.4.5 Recent Developments 3.5 Nordion 3.5.1 Company Profile 3.5.2 Main Business/Business Overview 3.5.3 Products, Services and Solutions 3.5.4 Nordion, Nuclear Medicine/Radiopharmaceutic Revenue (Million USD)(2014-2019) 3.5.5 Recent Developments 3.6 Triad Isotopes 3.6.1 Company Profile 3.6.2 Main Business/Business Overview 3.6.3 Products, Services and Solutions 3.6.4 Triad Isotopes, Nuclear Medicine/Radiopharmaceutic Revenue (Million USD)(2014-2019) 3.6.5 Recent Developments 3.7 Lantheus 3.7.1 Company Profile 3.7.2 Main Business/Business Overview 3.7.3 Products, Services and Solutions 3.7.4 Lantheus, Nuclear Medicine/Radiopharmaceutic Revenue (Million USD)(2014-2019) 3.7.5 Recent Developments 3.8 IBA Group 3.8.1 Company Profile 3.8.2 Main Business/Business Overview 3.8.3 Products, Services and Solutions 3.8.4 IBA Group, Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) (2014-2019) 3.8.5 Recent Developments 3.9 GE Healthcare 3.9.1 Company Profile 3.9.2 Main Business/Business Overview 3.9.3 Products, Services and Solutions 3.9.4 GE Healthcare, Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) (2014-2019) 3.9.5 Recent Developments 3.10 China Isotope & Radiation 3.10.1 Company Profile 3.10.2 Main Business/Business Overview 3.10.3 Products, Services and Solutions 3.10.4 China Isotope & Radiation, Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) (2014-2019) 3.10.5 Recent Developments Chapter 4 Global Nuclear Medicine/Radiopharmaceutic Market Size Type (2014-2019) 4.1 Global Nuclear Medicine/Radiopharmaceutic Market Size by Type (2014-2019) Chapter 5 Global Nuclear Medicine/Radiopharmaceutic Market Size Application (2014-2019) 5.1 Global Nuclear Medicine/Radiopharmaceutic Market Size by Application (2014-2019) 5.2 Potential Application of Nuclear Medicine/Radiopharmaceutic in Future 5.3 Top Consumer / End Users of Nuclear Medicine/Radiopharmaceutic Chapter 6 North America Nuclear Medicine/Radiopharmaceutic Development Status and Outlook 6.1 North America Nuclear Medicine/Radiopharmaceutic Market Size (2014-2019) 6.2 North America Nuclear Medicine/Radiopharmaceutic Market Size by Application (2014-2019) Chapter 7 EU Nuclear Medicine/Radiopharmaceutic Development Status and Outlook 7.1 EU Nuclear Medicine/Radiopharmaceutic Market Size (2014-2019) 7.2 EU Nuclear Medicine/Radiopharmaceutic Market Size by Application (2014-2019) Chapter 8 Japan Nuclear Medicine/Radiopharmaceutic Development Status and Outlook 8.1 Japan Nuclear Medicine/Radiopharmaceutic Market Size (2014-2019) 8.2 Japan Nuclear Medicine/Radiopharmaceutic Market Size by Application (2014-2019) Chapter 9 China Nuclear Medicine/Radiopharmaceutic Development Status and Outlook 9.1 China Nuclear Medicine/Radiopharmaceutic Market Size and Forecast (2014-2019) 9.2 China Nuclear Medicine/Radiopharmaceutic Market Size by Application (2014-2019) Chapter 10 India Nuclear Medicine/Radiopharmaceutic Development Status and Outlook 10.1 India Nuclear Medicine/Radiopharmaceutic Market Size and Forecast (2014-2019) 10.2 India Nuclear Medicine/Radiopharmaceutic Market Size by Application (2014-2019) Chapter 11 Southeast Asia Nuclear Medicine/Radiopharmaceutic Development Status and Outlook 11.1 Southeast Asia Nuclear Medicine/Radiopharmaceutic Market Size and Forecast (2014-2019) 11.2 Southeast Asia Nuclear Medicine/Radiopharmaceutic Market Size by Application (2014-2019) Chapter 12 Market Forecast by Regions and Application (2019-2025) 12.1 Global Nuclear Medicine/Radiopharmaceutic Market Size (Million USD) by Regions (2019-2025) 12.1. North America Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate (2019-2025) 12.1.2 EU Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate (2019-2025) 12.1.3 China Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate (2019-2025) 12.1.4 Japan Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate (2019-2025) 12.1.5 Southeast Asia Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate (2019-2025) 12.1.6 India Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate (2019-2025) 12.2 Global Nuclear Medicine/Radiopharmaceutic Market Size by Application (2019-2025) Chapter 13 Nuclear Medicine/Radiopharmaceutic Market Dynamics 13.1 Nuclear Medicine/Radiopharmaceutic Market Opportunities 13.2 Nuclear Medicine/Radiopharmaceutic Challenge and Risk 13.2.1 Competition from Opponents 13.2.2 Downside Risks of Economy 13.3 Nuclear Medicine/Radiopharmaceutic Market Constraints and Threat 13.3.1 Threat from Substitute 13.3.2 Government Policy 13.3.3 Technology Risks 13.4 Nuclear Medicine/Radiopharmaceutic Market Driving Force 13.4.1 Growing Demand from Emerging Markets 13.4.2 Potential Application Chapter 14 Market Effect Factors Analysis 14.1 Technology Progress/Risk 14.1.1 Substitutes 14.1.2 Technology Progress in Related Industry 14.2 Consumer Needs Trend/Customer Preference 14.3 External Environmental Change 14.3.1 Economic Fluctuations 14.3.2 Other Risk Factors Chapter 15 Research Finding /Conclusion Chapter 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.1.1 Research Programs/Design 16.1.2 Market Size Estimation 16.1.3 Market Breakdown and Data Triangulation 16.2 Data Source 16.2.1 Secondary Sources 16.2.2 Primary Sources 16.3 Disclaimer 16.4 Author List
1383

6902

OUR CLIENT